mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.03 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.03 |